Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

Autor: Coerver EME; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Fung WH; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., de Beukelaar J; Neurology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Bouvy WH; Neurology, Diakonessenhuis, Utrecht, the Netherlands., Canta LR; Neurology, Catharina Hospital, Eindhoven, the Netherlands., Gerlach OHH; Neurology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.; School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Hoitsma E; Neurology, Alrijne Hospital, Leiden, the Netherlands., Hoogervorst ELJ; Neurology, St Antonius Hospital, Utrecht, the Netherlands., de Jong BA; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Kalkers NF; Neurology, OLVG, Amsterdam, the Netherlands., van Kempen ZLE; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Lövenich H; Neurology, St Jans Gasthuis, Weert, the Netherlands., van Munster CEP; Neurology, Amphia Hospital, Breda, the Netherlands., van Oosten BW; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Smolders J; MS Center ErasMS, Neurology & Immunology, Erasmus Medical Center, Rotterdam, the Netherlands., Vennegoor A; Neurology, Flevoziekenhuis, Almere, the Netherlands., Zeinstra EMPE; Neurology, Isala Hospital, Meppel, the Netherlands., Barrantes-Cepas M; MS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Kooij G; MS Center Amsterdam, Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Schoonheim MM; MS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Moraal B; MS Center Amsterdam, Radiology & Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Barkhof F; MS Center Amsterdam, Radiology & Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, United Kingdom., Uitdehaag BMJ; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Mostert J; Neurology, Rijnstate Hospital, Arnhem, the Netherlands., Killestein J; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Strijbis EMM; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands.

Publikováno v: JAMA neurology [JAMA Neurol] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.

Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: Results of a nationwide Dutch clinical audit

Autor: Kuhrij, Laurien S., Marang-van de Mheen, Perla J., van den Berg-Vos, Renske M., de Leeuw, Frank-Erik, Nederkoorn, Paul J., Lingsma, H. F., de Borst, G. J., van Norden, A. G. W., Eysink Smeets, M. M., Aerden, L. A. M., Alblas, C. L., de Beer, F., Bienfait, H. P., Boon, A. E., Bor, S., Boreas, A. M. H. P., Bronner, I., Brouns, R., Brouwers, P. J. A. M., Brugman, F., Dane, M. L., Fransen, P. S. S., van Gemert, H. M. A., van Golde, A. E. L., de Graaf, M. T., Hani, L., van der Heijden, A. M. H. G., Hilkens, P. H., ten Holter, J. B. M., de Jong, S. W., Kapelle, L. J., Keizer, K., Keunen, R., Kloppenborg, R. P., Kok, A. J. M., Koops, L., Kruyt, N. D., de Leeuw, F. E., Lövenich, H., Luijckx, G. J., Maasland, E., Miedema, I., Nederkoorn, P. J., Persoon, S., Peters, E. W., van der Ree, T. C., Rozeman, A. D., Saxena, R., van Schaik, S., de Schryver, E. L. L. M., Schuiling, W. J., Schut, E. S., Staals, J. E. A., Stalpers, X., Tjeerdsma, H., van Tuijl, J. H., Vermeer, S. E., Visser, M. C., van den Wijngaard, I., van Zagten, M. S. G., Zylicz, S. A.

Publikováno v: BMC neurology, 19(1):265. BioMed Central
BMC Neurology, 19(1):265. BioMed Central Ltd
BMC Neurology
BMC Neurology, 19, 1
BMC Neurology, Vol 19, Iss 1, Pp 1-8 (2019)
BMC NEUROLOGY, 19(1):265. BioMed Central Ltd.
BMC Neurology, 19(1). BMC
BMC Neurology, 19

Background Intravenous thrombolysis (IVT) plays a prominent role in the treatment of acute ischemic stroke (AIS). The sooner IVT is administered, the higher the odds of a good outcome. Therefore, registering the in-hospital time to treatment with IVT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b802ad48976e535dc1c1815ee2fbaae7
https://pure.amc.nl/en/publications/determinants-of-extended-doortoneedle-time-in-acute-ischemic-stroke-and-its-influence-on-inhospital-mortality-results-of-a-nationwide-dutch-clinical-audit(62e62003-7340-4cd2-aa5f-4e4a1d04ad2f).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT.

Autor: Rüping MJ, Keulertz C, Vehreschild JJ, Lövenich H, Söhngen D, Wieland U, Cornely OA, Rüping, Maria J G T, Keulertz, Constance, Vehreschild, Jörg J, Lövenich, Harry, Söhngen, Dietmar, Wieland, Ulrike, Cornely, Oliver A

Publikováno v: Supportive Care in Cancer; Aug2011, Vol. 19 Issue 8, p1211-1216, 6p

ECTRIMS 2024 – Author Index.

Publikováno v: Multiple Sclerosis Journal; 2024 Suppl 3, Vol. 30, p1256-1312, 57p